Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VF Bioscience is a French biotechnology company specializing in the research and development of innovative functional ingredients and dietary supplements. The company focuses on the identification and characterization of specific probiotic strains and natural extracts with clinically proven health benefits, particularly in the areas of cardiovascular health, immune support, and metabolic balance. Their flagship product line, Reg'Activ, utilizes the unique Lactobacillus fermentum ME-3 strain, which is distinguished by its ability to stimulate the endogenous production of glutathione, a powerful antioxidant. VF Bioscience operates through a combination of proprietary research, academic collaborations, and international distribution of its specialized health solutions. The company is headquartered in the Eurasanté Bio-Business Park in Lille, France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VF Bioscience.